Winning Health Technology Group Toekomstige groei

Future criteriumcontroles 4/6

Winning Health Technology Group zal naar verwachting groeien in winst en omzet met respectievelijk 34.9% en 19.2% per jaar. De winst per aandeel zal naar verwachting groeien met 34.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 10.2% zijn.

Belangrijke informatie

34.9%

Groei van de winst

34.8%

Groei van de winst per aandeel

Healthcare Services winstgroei	29.8%
Inkomstengroei	19.2%
Toekomstig rendement op eigen vermogen	10.2%
Dekking van analisten	Good
Laatst bijgewerkt	01 Nov 2024

Recente toekomstige groei-updates

Recent updates

There May Be Underlying Issues With The Quality Of Winning Health Technology Group's (SZSE:300253) Earnings

Nov 05

Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 39%

Oct 10

Winning Health Technology Group (SZSE:300253) May Have Issues Allocating Its Capital

Aug 22

These 4 Measures Indicate That Winning Health Technology Group (SZSE:300253) Is Using Debt Reasonably Well

Jul 03

Impressive Earnings May Not Tell The Whole Story For Winning Health Technology Group (SZSE:300253)

May 03

Is Winning Health Technology Group (SZSE:300253) A Risky Investment?

Mar 19

Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 25%

Mar 01

Returns On Capital At Winning Health Technology Group (SZSE:300253) Paint A Concerning Picture

Feb 28

Winst- en omzetgroeiprognoses

SZSE:300253 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	4,835	794	N/A	773	8
12/31/2025	4,121	638	N/A	450	9
12/31/2024	3,331	429	N/A	726	3
9/30/2024	3,176	360	39	339	N/A
6/30/2024	3,195	372	61	385	N/A
3/31/2024	3,209	438	-134	168	N/A
12/31/2023	3,163	358	-129	185	N/A
9/30/2023	3,123	121	-253	82	N/A
6/30/2023	3,189	58	-296	24	N/A
3/31/2023	3,097	13	-234	107	N/A
1/1/2023	3,093	109	-223	100	N/A
9/30/2022	2,858	258	54	379	N/A
6/30/2022	2,822	333	143	461	N/A
3/31/2022	2,851	396	171	468	N/A
1/1/2022	2,750	378	82	368	N/A
9/30/2021	2,658	547	106	332	N/A
6/30/2021	2,498	528	112	312	N/A
3/31/2021	2,333	494	212	406	N/A
12/31/2020	2,267	491	203	390	N/A
9/30/2020	2,082	329	81	270	N/A
6/30/2020	2,032	311	-4	213	N/A
3/31/2020	1,939	353	13	213	N/A
12/31/2019	1,908	398	42	233	N/A
9/30/2019	1,712	384	-61	117	N/A
6/30/2019	1,561	347	30	194	N/A
3/31/2019	1,480	320	-6	161	N/A
12/31/2018	1,439	303	-43	124	N/A
9/30/2018	1,439	288	-93	91	N/A
6/30/2018	1,330	259	N/A	27	N/A
3/31/2018	1,242	243	N/A	-22	N/A
12/31/2017	1,204	229	N/A	80	N/A
9/30/2017	1,059	193	N/A	-57	N/A
6/30/2017	1,011	184	N/A	-26	N/A
3/31/2017	987	523	N/A	121	N/A
12/31/2016	954	519	N/A	140	N/A
9/30/2016	901	522	N/A	158	N/A
6/30/2016	852	517	N/A	101	N/A
3/31/2016	791	158	N/A	26	N/A
12/31/2015	753	153	N/A	79	N/A
9/30/2015	647	142	N/A	-48	N/A
6/30/2015	607	142	N/A	8	N/A
3/31/2015	536	127	N/A	22	N/A
12/31/2014	491	121	N/A	43	N/A
9/30/2014	402	100	N/A	62	N/A
6/30/2014	374	91	N/A	41	N/A
3/31/2014	358	84	N/A	47	N/A
12/31/2013	349	81	N/A	50	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei 300253 ( 34.9% per jaar) ligt boven de spaarquote ( 2.8% ).

Winst versus markt: De winst van 300253 ( 34.9% per jaar) zal naar verwachting sneller groeien dan de CN markt ( 26.1% per jaar).

Hoge groeiwinsten: De winst van 300253 zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van 300253 ( 19.2% per jaar) zal naar verwachting sneller groeien dan de markt CN ( 13.8% per jaar).

Hoge groei-inkomsten: De omzet van 300253 ( 19.2% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen 300253 zal naar verwachting over 3 jaar laag zijn ( 10.2 %).

Winning Health Technology Group Toekomstige groei

Future criteriumcontroles 4/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 13% to CN¥8.83

Price target decreased by 9.5% to CN¥8.14

Price target increased by 12% to CN¥9.08

Price target decreased by 7.5% to CN¥9.29

Consensus revenue estimates fall by 10%

Price target increased by 8.5% to CN¥12.35

Recent updates

There May Be Underlying Issues With The Quality Of Winning Health Technology Group's (SZSE:300253) Earnings

Price target increased by 13% to CN¥8.83

Third quarter 2024 earnings released: EPS: CN¥0.057 (vs CN¥0.064 in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 39%

New minor risk - Share price stability

Winning Health Technology Group Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 17%

Price target decreased by 9.5% to CN¥8.14

Second quarter 2024 earnings released: EPS: CN¥0.006 (vs CN¥0.037 in 2Q 2023)

Winning Health Technology Group (SZSE:300253) May Have Issues Allocating Its Capital

These 4 Measures Indicate That Winning Health Technology Group (SZSE:300253) Is Using Debt Reasonably Well

Winning Health Technology Group Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Dividend increased to CN¥0.02

Impressive Earnings May Not Tell The Whole Story For Winning Health Technology Group (SZSE:300253)

First quarter 2024 earnings released: EPS: CN¥0.008 (vs CN¥0.03 loss in 1Q 2023)

Full year 2023 earnings: EPS and revenues miss analyst expectations

Winning Health Technology Group Co., Ltd., Annual General Meeting, May 10, 2024

Price target increased by 12% to CN¥9.08

Winning Health Technology Group Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Is Winning Health Technology Group (SZSE:300253) A Risky Investment?

Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 25%

Returns On Capital At Winning Health Technology Group (SZSE:300253) Paint A Concerning Picture

Winning Health Technology Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 13, 2024

Price target decreased by 7.5% to CN¥9.29

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Consensus revenue estimates fall by 10%

Second quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Winning Health Technology Group Co., Ltd. to Report First Half, 2023 Results on Aug 18, 2023

Winning Health Technology Group Co., Ltd. Announces Final Dividend Implementation on Share A for 2022, Payable on June 15, 2023

Price target increased by 8.5% to CN¥12.35

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to CN¥10.04

Less than half of directors are independent

Consensus EPS estimates fall by 62%

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.016 (vs CN¥0.046 in 2Q 2021)

Winning Health Technology Group Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on July 15, 2022

Winning Health Technology Group Co., Ltd. Announces Final Dividend for 2021

Consensus EPS estimates fall by 23%

Price target decreased to CN¥11.04

First quarter 2022 earnings: EPS misses analyst expectations

Less than half of directors are independent

Winning Health Technology Group Co., Ltd. Proposes Final Dividend for 2021

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Consensus EPS estimates fall by 10%

Price target decreased to CN¥15.54

Investor sentiment deteriorated over the past week

Price target decreased to CN¥15.79

Price target decreased to CN¥17.39

Third quarter 2021 earnings released: EPS CN¥0.07 (vs CN¥0.061 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.046 (vs CN¥0.029 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.23 (vs CN¥0.19 in FY 2019)

Winning Health Technology Group Co., Ltd. to Report Fiscal Year 2020 Results on Apr 21, 2021

Price target lowered to CN¥20.45

Winning Health Technology Group Co., Ltd. Announces Board Appointments

New 90-day high: CN¥17.90

New 90-day low: CN¥14.86

New 90-day low: CN¥14.95

New 90-day low: CN¥15.54

New 90-day low: CN¥16.63

New 90-day low: CN¥17.79

Third quarter earnings released

Suqian Jingdong Tianning Health Technology Co., Ltd. and Wuxi AppTec Phase I Investment Enterprise (Limited Partnership) completed the acquisition of 8.6% stake in Shanghai Kingstar Winning Software Technology Co., Ltd. from Zhao Menghai and Winning Health Technology Group Co., Ltd. (SZSE:300253).

Earnings released

Winning Health Technology Group Co., Ltd. to Report First Half, 2020 Results on Aug 27, 2020

Winst- en omzetgroeiprognoses